Research suggests that intranasal nanosuspensions offer a promising way to formulate and deliver drugs that are poorly soluble in water to patients with chronic conditions.
Rajasekhar Jaladi, PhD
Advertisement
Rajasekhar Jaladi, PhD, jaladi.rajasekhar@gmail.com is associate vice president, drug metabolism and pharmacokinetics, for proprietary products, at Dr. Reddy’s.
Articles by Rajasekhar Jaladi, PhD
Advertisement
Latest Updated Articles
Assessment of Nanosuspension Formulation for Intranasal AdministrationPublished: September 3rd 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
2
Everything to Know About Pharmaceutical Tariffs in 2025
3
Challenges for the Global Manufacturing of Vaccines
4
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
5
